Free Newsletter
Clinic supply tool ready
Phase Forward continues its clinical trial software announcement blitz with two in the last week: an enhanced trial supply management system and a free tool to catch metadata errors.
The company's interactive response technology solution, IRT 5.0, is a result of last year's acquisition of Clarix. The system helps managers control clinical supply management to ensure supply availability at randomization.
The upgrade also boasts an integrated drug forecasting module for global trial supply management and--in keeping with the unofficial mandate for software upgrade announcements everywhere--an enhanced user interface. In the case of IRT 5.0, the interface enhancements include dashboard views that provide visual status alerts and filtering capabilities to guide users intuitively through tasks. The release also provides multilingual capabilities, including Japanese.
The drug forecasting module links to trial data on demand, allowing managers to compare assumptions and forecasts with actual trial data, update supply demand assumptions and modify manufacturing schedules. A smart system intelligence feature helps managers respond to sudden increases in subjects. On the basis of user-defined variables, the system generates supply orders or notifies the supply manager of a potential stock-out.
The free DefineValidator 1.0 release targets CDISC adopters. The tool was adapted from the WebSDM product, developed with the FDA to validate and review submission data in CDISC Study Data Tabulation Model (SDTM) format.
- see the IRT 5.0 announcement
- click here for the free DefineValidator download
Related Articles:
Data speed, accuracy gains feted
EDC pushes trial reporting to real time
Phase Forward boosts automation core
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: